SCHEMBL17824669

SCHEMBL17824669

NS(=O)(=O)c1ccc2c(c1)CN=CN2

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CA2 P00918 10/20 0.49
CA1 P00915 9/20 0.49
CA12 O43570 6/20 0.49
CA9 Q16790 5/20 0.49
PLAU P00749 1/20 0.47
PNMT P11086 6/20 0.46
ADRA2A P08913 1/20 0.46
ADRA2B P18089 1/20 0.46
ADRA2C P18825 1/20 0.46
CA7 P43166 3/20 0.45
CA14 Q9ULX7 3/20 0.45
ROCK1 Q13464 1/20 0.36
CA5A P35218 2/20 0.36
LMNA P02545 1/20 0.36
CA4 P22748 1/20 0.36
CA6 P23280 1/20 0.36
CA5B Q9Y2D0 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3238863 0.68 CA1 (0.81) CA2CA1CA12CA9PNMT
SCHEMBL29710882 0.68 CA1 (0.81) CA2CA1CA12CA9PNMT
SCHEMBL2710652 0.68 CA2 (0.41) CA2CA1CA12CA9PNMT
SCHEMBL29902411 0.67 MEN1 (0.63) CA2CA1CA12CA9PNMT
SCHEMBL689168 0.67 GAA (0.60) CA2CA1CA12CA9
SCHEMBL15009998 0.67 CA1 (0.51) CA2CA1CA12CA9PNMT
SCHEMBL17350895 0.67 CA1 (0.57) CA2CA1CA12CA9PNMT
SCHEMBL28218357 0.66 KMT2A (0.61) CA2CA1CA12CA9PNMT
SCHEMBL31236090 0.66 CA2 (0.50) CA2CA1CA12CA9CA7
SCHEMBL6955385 0.66 PNMT (0.81) CA2CA1CA12CA9PNMT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3230273-A1 2,4-DIOXO-QUINAZOLINE-6-SULFONAMIDE DERIVATIVES AS INHIBITORS OF PARG Cancer Research Technology Ltd (GB) 2017-10-18 EP disclosed
WO-2016092326-A1 2,4-DIOXO-QUINAZOLINE-6-SULFONAMIDE DERIVATIVES AS INHIBITORS OF PARG CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2016-06-16 WO disclosed